Lipid-Lowering Drugs and Pulmonary Vascular Disease: A Mendelian Randomization Study.

However, in the UKB dataset, this association showed only a borderline protective effect that did not reach statistical significance (Table 2 : OR = 0.998, 95% CI = 0.996–1.000, p > 0.05; Figure 2 ).

also in 111,027 other papers